bibliographicCitation |
Zhang W, Du C, Sun Y, Yang L, Cui C, Jiang Z, Wang C, Wang J, Zhou A. Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. Cancer Chemotherapy and Pharmacology. 2018 Jul 23;82(4):655–60. doi: 10.1007/s00280-018-3650-4. |